HM-A42 / Hutchmed - LARVOL DELTA

[VIRTUAL] OVERALL SURVIVAL (OS) AND QUALITY OF LIFE (QOL) OF OLDER ADULTS DIAGNOSED WITH ACUTE MYELOID LEUKEMIA (AML) AND TREATED UNDER CONDITIONS OF USUAL CLINICAL PRACTICE: INTERIM REPORT OF THE SVLMA STUDY (EHA 2020) - "Median BM blast cells were different (ITV 53%, ATT 74.8%, HMA 42.5%, BSC 52.5%; P<0.001)...AML has a great impact on QoL at Dx and reported asthenia is prominent. Although ECOG PS and LEE scores are associated with the clinical decision and Rx strategy followed, GAH score is not."

Clinical • HEOR • Acute Myelogenous Leukemia • Hematological Disorders • Hematological Malignancies • Leukemia • Oncology • FLT3 • NPM1